Some health companies are selling massive lab panels directly to consumers often with questionable medical value and zero real follow-up. We sit down with the Barbell Medicine crew to expose the risks, the marketing tactics, and the right way to approach lab testing without getting scammed.

ChatGPT said: CVS Caremark just dropped Zepbound from its formulary, forcing countless patients to switch to Wegovy. In this episode, we break down why it happened, how PBMs are calling the shots, and what patients can actually do about it.

Monjaro just dropped hot new trial results and they might show it helps you live longer. We break down the Surpass CVOT, compare it to Trulicity, and explain what this all means for your heart, kidneys, and overall health.

Can higher doses of semaglutide really deliver better results, without the side effects? In this episode of Docs Who Lift, Dr. Spencer Nadolsky and Dr. Karl Nadolsky Jr. sit down with Canadian obesity expert and clinical trialist Dr. Sean Wharton to break down the latest data from the STEP-UP trial. They dig into the science behind tripling the dose of semaglutide, how it compares to drugs like tirzepatide, and what it means for the future of obesity treatment.

Summary In this episode of the Docs Who Live podcast, Dr. Spencer Nadolsky and Dr. Karl Ndolsky Jr. engage with Dr. Jackie Yao and Dr. Michael Blaha from Johns Hopkins to discuss a recent study on obesity. They explore the definitions of clinical and anthropometric obesity, the challenges in classifying obesity, and the implications of the Lancet Commission's criteria. The conversation delves into the nuances of metabolic health, the importance of data sources, and future research directions in understanding obesity and its related health risks.

Drs. Karl and Spencer talk to friend and retina specialist Dr. Eric Brugger about the new report of age-related macular degeneration along with an update on NAION.

In this episode of the Docs Who Lift podcast, Drs. Karl and Spencer. welcome Dr. Beverly Tchang, an associate professor and obesity specialist at Cornell. The conversation delves into the complexities of menopausal hormonal therapy with GLP-1 medicine in women, and the impact of hormonal changes on weight loss. They discuss the nuances of hormonal replacement therapy, the influence of the wellness industry, and the importance of a holistic approach to women's health. Dr. Tchang shares insights from her recent post-hoc analysis on tirzepatide and its effects on women in different reproductive stages, emphasizing the need for more rigorous research in this area.

In this episode of the Docs Who Lift podcast, Drs. Karl, Spencer, and Grant discuss the latest research on muscle growth, body composition, and the effects of GLP-1 receptor agonists. They delve into the role of myostatin in muscle regulation, the implications of recent trials on muscle mass loss, and the importance of exercise in maintaining muscle health. The conversation also touches on MRI data regarding muscle volume and the future of muscle-enhancing medications.

In this episode of the Docs Who Lift podcast, Dr. Spencer Nadolsky and Dr. Karl engage with Dr. Kevin Klatt to discuss the recent MAHA report and its implications for dietary guidelines and nutrition science. They explore the historical context of dietary guidelines, the challenges of funding nutrition research, and the political dynamics surrounding public health recommendations. The conversation highlights the disconnect between public perception and scientific evidence, as well as the need for a more robust investment in nutrition research to address chronic diseases and obesity. In this conversation, the speakers discuss the current state of food policy and nutrition science, highlighting the disconnect between political promises and actual changes in regulations. They critique the focus on superficial issues while neglecting more pressing health concerns, such as obesity and food safety. The conversation emphasizes the need for better funding and research in nutrition, the importance of expert opinions, and the dangers of misinformation in public health messaging.

Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions. Learn how to stop chasing perfection and embrace connection.

In this episode of the Docs Who Lift podcast, Dr. Spencer Nadolsky and Dr. Karl discuss the latest findings from the SURMOUNT-5 on Zepbound (tirzepatide) vs. Wegovy (semaglutide,) two leading medications for weight loss and type 2 diabetes. They explore the efficacy, safety, and cost-effectiveness of these drugs, highlighting the significant weight loss outcomes associated with tirzepatide compared to semaglutide. The conversation also delves into the importance of patient stewardship in prescribing these medications, the impact of gender differences on weight loss results, and the need for more affordable options in the market.

In this episode, Spencer and Karl discuss a recent study on semaglutide for treating metabolic dysfunction associated steatotic liver disease (MASH). They explore the implications of the study, the Essence trial, and the potential of new treatments for obesity and liver health. The conversation also touches on the importance of early treatment and the need for more accessible medication options.

Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women.

Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case of tirzepatide induced anhedonia.

Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.

Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine.

Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is lost with tirzepatide, the most powerful medicine available for weight loss.

Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.

Drs. Karl and Spencer chat with NAD metabolism expert Dr. Charles Brenner all about these supposed longevity supplements.

Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes.